Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine-Reference-Cited by-同舟云学术

Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine

Published:2011-09-09 Issue:19 Volume:103 Page:1444-1451
ISSN:1460-2105
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Kreimer Aimée R.¹,Rodriguez Ana Cecilia¹,Hildesheim Allan¹,Herrero Rolando¹,Porras Carolina¹,Schiffman Mark¹,González Paula¹,Solomon Diane¹,Jiménez Silvia¹,Schiller John T.¹,Lowy Douglas R.¹,Quint Wim¹,Sherman Mark E.¹,Schussler John¹,Wacholder Sholom¹,

Affiliation:

1. Affiliations of authors: Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics (ARK, AH), Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics (MES), Biostatistics Branch, Division of Cancer Epidemiology and Genetics (SW), Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics (MS), Breast and Gynecologic Cancer Research Group, Divis

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/103/19/1444/17311156/djr319.pdf

Reference20 articles.

1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008;Ferlay;Int J Cancer.,2010

2. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women;Paavonen;Lancet.,2009

3. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions;FUTURE II Study Group;N Engl J Med.,2007

4. Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications;Goldie;Reprod Health Matters.,2008

5. National, state, and local area vaccination coverage among adolescents aged 13–17 years—United States, 2008;Centers for Disease Control and Prevention;MMWR Morb Mortal Wkly Rep.,2009

Cited by 265 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the seroprevalence of human papillomavirus in Guangdong, China: Implications for vaccination strategies;Journal of Medical Virology;2024-09

2. The Clinical Effectiveness of Single-Dose Human Papillomavirus Vaccination;Vaccines;2024-08-23

3. Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to multidose vaccination regimens or no vaccination: An updated systematic review of evidence from clinical trials;Vaccine: X;2024-08

4. Potential impact of switching from a two- to one-dose gender-neutral routine HPV vaccination program in Canada: A mathematical modeling analysis;2024-05-29

5. The clinical effectiveness of one-dose vaccination with an HPV vaccine: A meta-analysis of 902,368 vaccinated women;PLOS ONE;2024-01-05